Diabetes
Conditions
Interventions
Using only Mediwalk
Using Mediwalk and Smiledatavision
Sponsors
Kanazawa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) HbA1c >=9 % 2) Type 2 diabetes (no restriction of prescription medication) 3) Possible to prescribed blood sampling in hospitals 4) 20-years-old and above 5) Individuals capable of giving voluntary, informed consent in writing 6) Permission of sub-investigator (doctor)
Exclusion criteria
Exclusion criteria: ) Using of walking intensity monitor over the past 3 months 2) Exercise contraindication 3) Participating in another clinical study 4) Pregnant or possibility of pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| activity mass (consumption energy, count of steps, time of moderately intense walking) | — |
Secondary
| Measure | Time frame |
|---|---|
| PAID, HbA1c, TC, HDL-C, TG, weight, blood pressure, abdominal circumference, boundary length of lower leg, rate of antidiabetes drugs, rate of antihypertensive drugs use, rate of antihyperlipidemic drug use, fasting glucose level, AST, ALT, r-GTP, relationship between PAID and activity mass, relationship between HbA1c and activity mass | — |
Countries
Japan
Contacts
Public ContactRyo Matsushita
Kanazawa University Faculty of Pharmacy, Institute of Medical, Pharmaceutical Sciences
Outcome results
None listed